Could a rice bran supplement ease chemo side effects?

NCT ID NCT07503496

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether a dietary supplement called Biobran, made from rice bran, can help women with stage I-III breast cancer who are receiving chemotherapy. The goal is to see if it reduces side effects and improves quality of life. About 96 participants will take Biobran daily for 24 weeks while researchers monitor their symptoms, tumor size, and blood tests.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Biobran (rice bran arabinoxylan)
What this could lead to
If it works, this could point toward a simple dietary supplement that helps breast cancer patients feel better during chemotherapy.
What could go wrong
This is a small, early-stage trial with only 96 participants. The supplement may not reduce side effects or improve quality of life more than a placebo.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER STAGE III are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • China Medical University

    NOT_YET_RECRUITING

    Taichung, 406040, Taiwan

    Contact

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact

    Contact

  • China Medical University Hospital

    RECRUITING

    Taichung, 406040, Taiwan

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.